This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yuki Ohte: Innovator in Cancer Research
Introduction
Yuki Ohte is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of cancer research, particularly in the area of drug sensitivity prediction.
Latest Patents
Yuki Ohte holds a patent titled "Method for Predicting Sensitivity of Cancer Cell to Helicase Inhibitor." This innovative method aims to enhance the effectiveness of cancer treatments by predicting how cancer cells respond to specific inhibitors.
Career Highlights
Ohte is currently employed at Chugai Pharmaceutical Co., Ltd., where he continues to advance his research in oncology. His work is pivotal in developing targeted therapies that can improve patient outcomes.
Collaborations
Yuki collaborates with talented colleagues, including Mayumi Soga and Hiroshi Sakamoto, who contribute to his research efforts and help drive innovation in the field.
Conclusion
Yuki Ohte's work exemplifies the impact of innovative research in cancer treatment. His contributions are vital for the future of oncology and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile